Market Trends of China Computed Tomography Industry
Diagnostic Centers to Hold Significant Share in End-User Segment Over the Forecast Period
Diagnostic centers are the major end users of computed tomography and are expected to witness a significant share in the segment.
Factors such as the high frequency of dental and cardiovascular ailments, orthopedic diseases, and cancer, strategic efforts by leading companies, and huge investments in the healthcare industry are likely to drive segment growth. Additionally, population awareness of CT imaging services is projected to increase market growth.
The country's growing burden of chronic diseases requires imaging diagnosis, which is likely to boost the segment growth. For instance, according to a study published in Biomedical and Environmental Science in July 2022, CVD affected around 330 million individuals in China in 2021. There are 13.00 million, 11.39 million, 8.90 million, 5.00 million, 4.87 million, 2.50 million, 2.00 million, 45.30 million, and 245.00 million patients suffering from stroke, coronary heart disease, heart failure, pulmonary heart disease, atrial fibrillation, rheumatic heart disease, congenital heart disease, lower extremity artery disease, and hypertension, respectively. Thus, the huge burden of cardiac diseases is expected to rise in demand for effective diagnosis and thus boost segment growth.
Strategic collaboration and partnership in the segment propel the market growth in the country. For instance, in April 2021, AstraZeneca and Geneseeq Technology Inc. collaborated strategically to establish the Bio-Diagnostic Innovation Center in China. The collaboration also includes establishing a clinical diagnostics laboratory for creating an integrated and patient-centric disease diagnosis, treatment, and rehabilitation for cancer patients.
Hence, with the abovementioned factors, diagnostic centers are believed to play a crucial role in the computed tomography market in China.
Neurology Segment is Expected to Hold Significant Share Over the Forecast Period
The factors propelling the segment's growth are an increase in neurological disorders, huge investments by private players in neurology devices, and product launches by the market players.
Many neurological disorders share certain characteristics, and a CT scan can aid in proper diagnosis by differentiating the area of the brain affected by the disorder. The ultimate goal of a CT scan is to provide a clearer brain structure for diagnosis. In the majority of brain diseases, such as vertigo, skull fracture, cerebral infarction, Alzheimer's, and epilepsy, CT images aim to distinguish abnormalities in the structure. Moreover, a growing aging population, which is more prone to neurological diseases, is expected to boost the market growth over the forecast period.
According to the data published by the China Alzheimer Report 2022, China's population of Alzheimer's disease patients is about six million, with the percentage of individuals with dementia being 5%, 11.5%, and 30% among 65-, 75-, and 85-year-olds. Further, according to the study published in the Atmospheric Environment in August 2022, In China, about 10 million people had epilepsy in 2021. Epilepsy has neurological, cognitive, psychological, and social consequences. People with epilepsy have a two to four times higher risk of fatal injuries. Thus, the huge burden of neurological diseases is expected to rise in demand for effective diagnosis, which will likely propel the demand for CT in China, boosting the segment growth.
Thus, all factors above are expected to boost the segment growth over the forecast period.
